Stay updated with breaking news from Alanh Auerbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Puma Biotechnology, Inc. , a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2023. Unless otherwise stated, all comparisons are for the...
Transition to Profitability Amidst Operational Adjustments and Clinical Developments
Puma Biotechnology, Inc. , a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend TD Cowen’s 44th Annual Health...
HC Wainwright reiterated their buy rating on shares of Puma Biotechnology (NASDAQ:PBYI – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $8.00 price target on the biopharmaceutical company’s stock. Separately, StockNews.com upgraded shares of Puma Biotechnology from a buy rating to a strong-buy rating in a […]
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the initiation of its ALISertib in CAncer (ALISCA-Lung1) Phase II trial (PUMA-ALI-4201; NCT06095505) of alisertib monotherapy for the treatment of patients with extensive stage small...